24905232

Wu C

2014

The characterization of obese polycystic ovary syndrome rat model suitable for exercise intervention.

24905277

Wojtkiewicz J

2014

Innervation pattern of polycystic ovaries in the women.

24905723

Tuten A

2014

Evaluation of ovarian reserve in Hashimoto's thyroiditis.

24906976

Glintborg D

2014

Adiponectin, interleukin-6, monocyte chemoattractant protein-1, and regional fat mass during 12-month randomized treatment with metformin and/or oral contraceptives in polycystic ovary syndrome.

24909750

Shorakae S

2014

Polycystic ovary syndrome: a common hormonal condition with major metabolic sequelae that physicians should know about.

24910644

Ramezani Tehrani F

2014

The time of prenatal androgen exposure affects development of polycystic ovary syndrome-like phenotype in adulthood in female rats.

24913417

Pasquali R

2015

Metformin in women with PCOS, pros.

24914605

Frary JM

2016

The effect of dietary carbohydrates in women with polycystic ovary syndrome: a systematic review.

24916516

Karsli MF

2014

Do we need readjustment of the biochemical parameters in first trimester combined aneuploidy screening test in women with polycystic ovary syndrome?

24918529

de Medeiros SF

2014

Is glycated hemoglobin related to other dysmetabolic variables implicated in the increase of cardiovascular risk in polycystic ovary syndrome? A comparative study.

24918699

Lemos AJ

2014

Effect of the combination of metformin hydrochloride and melatonin on oxidative stress before and during pregnancy, and biochemical and histopathological analysis of the livers of rats after treatment for polycystic ovary syndrome.

24918718

Avila MA

2014

[Polycystic ovary syndrome: the visible and invisible associate with cardiovascular risk].

24918723

Avila MA

2014

Polycystic ovary syndrome: implications of metabolic dysfunction.

24919033

Bhagavath B

2014

Metformin and other insulin sensitizers in polycystic ovary syndrome.

24920281

Ademoglu EN

2014

Plasma nesfatin-1 levels are increased in patients with polycystic ovary syndrome.

24921163

Turner-McGrievy G

2015

Dietary intake, eating behaviors, and quality of life in women with polycystic ovary syndrome who are trying to conceive.

24923289

Morandi A

2014

Predictors of metabolic risk in childhood obesity.

24925927

Gibson-Helm ME

2014

Women's experiences of polycystic ovary syndrome diagnosis.

24927076

Sunj M

2014

Assessment of ovarian reserve after unilateral diathermy with thermal doses adjusted to ovarian volume.

24927079

Wang L

2014

Elevated serum chemerin in Chinese women with hyperandrogenic PCOS.

24927080

Gallea M

2014

Insulin and body weight but not hyperandrogenism seem involved in seasonal serum 25-OH-vitamin D3 levels in subjects affected by PCOS.

24927491

Sabbaghi M

2014

IL-17A concentration of seminal plasma and follicular fluid in infertile men and women with various clinical diagnoses.

24928355

Palomba S

2014

Early trophoblast invasion and placentation in women with different PCOS phenotypes.

24928911

K?ninger A

2014

Serum concentrations of afamin are elevated in patients with polycystic ovary syndrome.

24929454

Cheng KJ

2014

Neurobiological mechanisms of acupuncture for some common illnesses: a clinician's perspective.

24929892

Stuckey BG

2014

Clustering of metabolic and cardiovascular risk factors in the polycystic ovary syndrome: a principal component analysis.

24931701

Capula C

2014

Prevalence and predictors of postpartum glucose intolerance in Italian women with gestational diabetes mellitus.

24933120

Irani M

2014

Role of vitamin D in ovarian physiology and its implication in reproduction: a systematic review.

24933126

Gourgari E

2014

Vitamin B12 deficiency in an adolescent girl with polycystic ovarian syndrome.

24933845

Clark CM

2014

Dermatologic manifestation of hyperandrogenism: a retrospective chart review.

24940414

Zhang J

2014

Plasma visfatin levels and mRNA expression of visfatin in peripheral blood mononuclear cells and peripheral blood monocyte-derived macrophages from normal weight females with polycystic ovary syndrome.

24941435

Zhang YY

2014

Effects of acarbose on polycystic ovary syndrome: a meta-analysis.

24943040

Cloix L

2014

Expression and regulation of INTELECTIN1 in human granulosa-lutein cells: role in IGF-1-induced steroidogenesis through NAMPT.

24944918

Soliman A

2014

Continuous glucose monitoring system and new era of early diagnosis of diabetes in high risk groups.

24944925

Joshi B

2014

A cross-sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai, India.

24944933

Shabir I

2014

Prevalence of metabolic syndrome in the family members of women with polycystic ovary syndrome from North India.

24945113

Palomba S

2014

Lipid profile in nonobese pregnant women with polycystic ovary syndrome: a prospective controlled clinical study.

24946636

Chen R

2014

[Observation on therapeutic effect of polycystic ovary syndrome of damp-phlegm constitution treated with embedding therapy on back-shu points and front-mu points combined with needle-pricking therapy on Sifeng (EX-UE 10)].

24947064

Du J

2014

Family-based analysis of INSR polymorphisms in Chinese PCOS.

24948985

Silfeler DB

2014

Evaluation of Mean Platelet Volume values in lean women with polycystic ovary syndrome.

24951490

Dahhan T

2014

Reproductive choices and outcomes after freezing oocytes for medical reasons: a follow-up study.

24956291

Bryant C

2014

Asptects of mental health care in the gynecological setting.

24956415

Asemi Z

2015

DASH diet, insulin resistance, and serum hs-CRP in polycystic ovary syndrome: a randomized controlled clinical trial.

24956549

Gonz?lez F

2014

Evidence of mononuclear cell preactivation in the fasting state in polycystic ovary syndrome.

24959880

Liu Q

2014

Vitamin B12 status in metformin treated patients: systematic review.

24960542

Louwers YV

2014

The impact of self-reported ethnicity versus genetic ancestry on phenotypic characteristics of polycystic ovary syndrome (PCOS).

24961320

K?ninger A

2014

Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndrome.

24962189

Kelly CT

2014

Hyperinsulinemic syndrome: the metabolic syndrome is broader than you think.

24963163

De Fr?ne V

2014

A retrospective study of the pregnancy, delivery and neonatal outcome in overweight versus normal weight women with polycystic ovary syndrome.

24963167

Kuhtz J

2014

Human in vitro oocyte maturation is not associated with increased imprinting error rates at LIT1, SNRPN, PEG3 and GTL2.

24963365

Gharakhani M

2011

Is reducing ovarian volume in polycystic ovarian syndrome patients after administration of metformin associated with improving cardiovascular risk factors?

24963493

Zhuo Z

2014

Effect of metformin intervention during pregnancy on the gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and meta-analysis.

24965976

Bili E

2014

The combination of ovarian volume and outline has better diagnostic accuracy than prostate-specific antigen (PSA) concentrations in women with polycystic ovarian syndrome (PCOs).

24965979

Shavit T

2014

In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?

24965999

Sunj M

2014

Anti-M?llerian hormone, testosterone and free androgen index following the dose-adjusted unilateral diathermy in women with polycystic ovary syndrome.

24966697

Berger JJ

2014

Optimal management of subfertility in polycystic ovary syndrome.

24966936

Huang B

2014

Antioxidant capacity of follicular fluid from patients undergoing in vitro fertilization.

24969481

Grolmusz VK

2014

Genetic variants of the HSD11B1 gene promoter may be protective against polycystic ovary syndrome.

24971120

Azargoon A

2013

Effects of simvastatin pretreatment on clomiphene response in clomiphene - resistant women with polycystic ovary syndrome.

24971127

Foroozanfard F

2014

Obstetric and Neonatal Outcome in PCOS with Gestational Diabetes Mellitus.

24971613

Leblanc S

2014

Angiotensin II type 2 receptor stimulation improves fatty acid ovarian uptake and hyperandrogenemia in an obese rat model of polycystic ovary syndrome.

24971785

Leanza V

2014

Ovulation induction with clomiphene citrate and metformin in women with polycystic ovary syndrome.

24971918

Lenarcik-Kabza A

2014

The influence of endocannabinoid receptor 1 gene variations on anthropometric and metabolic parameters of women with polycystic ovary syndrome.

24971919

Zachurzok A

2014

Social abilities and gender roles in adolescent girls with polycystic ovary syndrome - a pilot study.

24973036

Cankaya S

2014

Insulin resistance and its relationship with high molecular weight adiponectin in adolescents with polycystic ovary syndrome and a maternal history of polycystic ovary syndrome.

24973357

DePaoli AM

2014

20 years of leptin: leptin in common obesity and associated disorders of metabolism.

24973798

Huang Y

2014

Cryptotanshinone reverses ovarian insulin resistance in mice through activation of insulin signaling and the regulation of glucose transporters and hormone synthesizing enzymes.

24974842

Micskei O

2014

[Body image and quality of life in women with polycystic ovary syndrome].

24978853

Leader B

2014

Maximizing the clinical utility of antim?llerian hormone testing in women's health.

24980253

Persani L

2014

The fundamental role of bone morphogenetic protein 15 in ovarian function and its involvement in female fertility disorders.

24983549

Serret-Montoya J

2014

[Menstrual pattern characteristics in female adolescents with epilepsy].

24986529

Peng CY

2014

The association between androgen receptor gene CAG polymorphism and polycystic ovary syndrome: a case-control study and meta-analysis.

24992182

Xu N

2014

Early embryonic androgen exposure induces transgenerational epigenetic and metabolic changes.

24992778

Hu L

2014

Treatment of polycystic ovarian syndrome with insulin resistance by insulin-sensitizer.

24992782

Jiao J

2014

Epidemiologic investigation of polycystic ovarian syndrome (PCOS) in Han ethnic women of reproductive age in Liaoning Province, China.

24992783

Yildirim B

2014

Adropin: a key component and potential gatekeeper of metabolic disturbances in policystic ovarian syndrome.

24993116

Ben Salem A

2014

Common polymorphisms of calpain-10 and the risk of polycystic ovary syndrome in Tunisian population: a case-control study.

24994518

Cazorla A

2014

Polycystic ovary syndrome as a rare association with inflammatory hepatocellular adenoma: a case report.

24995854

Yilmaz ?

2014

Lower cocaine- and amphetamine-regulated transcript levels pose a risk for developing PCOS.

24995944

Hashemi S

2014

Association of PCOS and its clinical signs with sexual function among Iranian women affected by PCOS.

24996451

Nouri K

2014

Predictive factors for recovery time in patients suffering from severe OHSS.

25000958

Targher G

2014

Hemostatic and fibrinolytic abnormalities in polycystic ovary syndrome.

25001653

Zhang J

2014

Environmental risk factors for women with polycystic ovary syndrome in china: a population-based case-control study.

25003228

Helvaci N

2014

Oral contraceptives in polycystic ovary syndrome.

25003376

Sopher AB

2014

Anti-Mullerian hormone may be a useful adjunct in the diagnosis of polycystic ovary syndrome in nonobese adolescents.

25005453

Zehir R

2014

Assessment of atrial conduction time in patients with polycystic ovary syndrome.

25005769

Zhao J

2014

Association between single nucleotide polymorphisms of sterol regulatory element binding protein-2 and liver X receptor ? gene and risk of polycystic ovary syndrome in a Chinese Han population.

25006485

Gerv?sio CG

2014

The role of androgen hormones in early follicular development.

25006718

Legro RS

2014

Letrozole versus clomiphene for infertility in the polycystic ovary syndrome.

25008465

Goodarzi MO

2015

DHEA, DHEAS and PCOS.

25009730

Ellenbogen A

2014

IVM results are comparable and may have advantages over standard IVF.

25010619

Erkan M

2014

Are insulin resistance and serum resistin levels increased in women with idiopathic hirsutism?

25010620

Bizzarri M

2014

Inositol: history of an effective therapy for Polycystic Ovary Syndrome.

25011417

Sari U

2014

Is pentraxin 3 a new cardiovascular risk marker in polycystic ovary syndrome?

25011927

Voelkl J

2014

Up-regulation of hepatic alpha-2-HS-glycoprotein transcription by testosterone via androgen receptor activation.

25012254

Czeczuga-Semeniuk E

2015

Assessment of FSHR, AMH, and AMHRII variants in women with polycystic ovary syndrome.

25013215

Sivalingam VN

2014

Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indications.

25013687

Rajaeieh G

2014

The Relationship between Intake of Dairy Products and Polycystic Ovary Syndrome in Women Who Referred to Isfahan University of Medical Science Clinics in 2013.

25015747

Ismail AM

2014

Adding L-carnitine to clomiphene resistant PCOS women improves the quality of ovulation and the pregnancy rate. A randomized clinical trial.

25015812

Reynolds LP

2014

Placental vascular defects in compromised pregnancies: effects of assisted reproductive technologies and other maternal stressors.